2. Academic Validation
  3. Identification of a small molecule with activity against drug-resistant and persistent tuberculosis

Identification of a small molecule with activity against drug-resistant and persistent tuberculosis

  • Proc Natl Acad Sci U S A. 2013 Jul 2;110(27):E2510-7. doi: 10.1073/pnas.1309171110.
Feng Wang 1,  Dhinakaran Sambandan,  Rajkumar Halder,  Jianing Wang,  Sarah M Batt,  Brian Weinrick,  Insha Ahmad,  Pengyu Yang,  Yong Zhang,  John Kim,  Morad Hassani,  Stanislav Huszar,  Claudia Trefzer,  Zhenkun Ma,  Takushi Kaneko,  Khisi E Mdluli,  Scott Franzblau,  Arnab K Chatterjee,  Kai Johnsson,  Katarina Mikusova,  Gurdyal S Besra,  Klaus Fütterer,  Scott H Robbins,  S Whitney Barnes,  John R Walker,  William R Jacobs Jr,  Peter G Schultz
Affiliations

Affiliation

  • 1 Department of Chemistry, The Scripps Research Institute, La Jolla, CA 92037, USA.
PMID: 23776209 DOI: 10.1073/pnas.1309171110
Abstract

A cell-based phenotypic screen for inhibitors of biofilm formation in mycobacteria identified the small molecule TCA1, which has bactericidal activity against both drug-susceptible and -resistant Mycobacterium tuberculosis (Mtb) and sterilizes Mtb in vitro combined with rifampicin or isoniazid. In addition, TCA1 has bactericidal activity against nonreplicating Mtb in vitro and is efficacious in acute and chronic Mtb Infection mouse models both alone and combined with rifampicin or isoniazid. Transcriptional analysis revealed that TCA1 down-regulates genes known to be involved in Mtb persistence. Genetic and affinity-based methods identified decaprenyl-phosphoryl-β-D-ribofuranose oxidoreductase DprE1 and MoeW, Enzymes involved in cell wall and molybdenum cofactor biosynthesis, respectively, as targets responsible for the activity of TCA1. These in vitro and in vivo results indicate that this compound functions by a unique mechanism and suggest that TCA1 may lead to the development of a class of antituberculosis agents.

Keywords

drug resistance; dual mechanism.

Figures
Products
  • Cat. No.
    Product Name
    Description
    Target
    Research Area
  • HY-12904
    98.29%, 抗结核剂
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z